HLMN Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress XP Q1 2026 Earnings EPS Miss and Stock Decline Signal Headwinds STRK Q1 2026 Earnings Massive EPS Miss as Preferred Stock Posts Steep Loss LivaNova PLC LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Stock Slips CCU Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction